News
Amneal Pharmaceuticals, Inc. ( NASDAQ: AMRX) Q1 2025 Earnings Call May 2, 2025 8:30 AM ET Tony DiMeo - Head, Investor Relations Chirag Patel - Co-Founder and Co-Chief Executive Officer Chintu Patel - ...
Discover Amneal Pharmaceuticals' Q1 2025 insights, featuring revenue growth, CREXONT’s expansion, biosimilar contributions, and innovative drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback